Skip to main content

Day: February 3, 2025

Ackroo to Hold Annual and Special Meeting for the Sale of Ackroo to Paystone on February 24, 2025

Ackroo confirms meeting date, Paystone financing, change to outside date and files meeting materials HAMILTON, Ontario, Feb. 03, 2025 (GLOBE NEWSWIRE) — Ackroo Inc. (TSX-V: AKR; OTC: AKRFF) (the “Company” or “Ackroo”), a gift card, loyalty marketing, payments and point-of-sale technology consolidator and services provider, is pleased to announce its annual general and special meeting (the “Meeting”) for the shareholders of the Company (the “Shareholders”) to consider and approve the sale of Ackroo to Paystone Inc. (“Paystone”) will take place on February 24, 2025 at 10:00 p.m. (Eastern Time). Since the announcement of signing the arrangement agreement among the Company, Paystone and a subsidiary of Paystone, Atom Growth Inc. dated December 12, 2024 (as may be amended, supplemented or otherwise modified from time to time, the “Arrangement...

Continue reading

Skyward Specialty to Host Fourth Quarter 2024 Earnings Call Wednesday, February 26, 2025

HOUSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group, Inc.™ (NASDAQ: SKWD) (“Skyward Specialty” or “the Company”) expects to issue its fourth quarter 2024 earnings results after the market closes on Tuesday, February 25th which will be available on the Company website at investors.skywardinsurance.com/ under Quarterly Results. Skyward Specialty will host its earnings call to review the fourth quarter 2024 financial results on Wednesday, February 26 at 9:30 a.m. EDT. Investors may access the live audio webcast via the link on the Company’s investor site at investors.skywardinsurance.com/ under Events & Presentations. Additionally, investors can access the earnings call via conference call by registering via the conference link. Users will receive dial-in information and...

Continue reading

Bavarian Nordic Reports Preliminary 2024 Financial Results in Line with Upgraded Guidance and Guides for 2025

Travel Health business demonstrated strong growth of 22%. Additional mpox vaccine orders during outbreak drove higher revenues for the Public Preparedness business and also secured a strong foundation for 2025. Financial guidance for 2025 in line with the Company’s 2024-2027 ambitions.COPENHAGEN, Denmark, February 3, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced preliminary, unaudited financial results for 2024 and provided its financial guidance for 2025. The preliminary revenue in 2024 was DKK 5,716 million and was comprised of the following:Revenue from Public Preparedness was DKK 3,206 million, reaching the midpoint of the guided interval of DKK 3,000 – 3,400 million. This is more than 1,000 million above the projected base business and reflects another spike year of sales, as the Company addressed the second public health...

Continue reading

Tonner Drones: “Our listing on the stock market has attracted interest.”

Tonner Drones: “Our listing on the stock market has attracted interest.” Schiltigheim, February 3, 2025, 18:15, Tonner Drones (’the Company’) is pleased to announce that in the recent period various parties showed interest in working together under the listed entity.Discussions are part of the new strategy of Tonner Drones Possible collaborations should create significant value for shareholders. At the same time Tonner Drones announces first revenue from its Consulting Business worth €61.000.Tonner Drones announced in September that its new strategy focusses on three pillars:1) It will continue to develop and commercialize Countbot. For the Inhibitor it is committed to find partners to develop the product and to maximize the value of the patents.2) The company started her consulting and investment business.3) Tonner Drones...

Continue reading

Regulated information – Disclosure of share buy-back transactions – From 27 January 2025 to 31 Janurary 2025

In compliance with share buyback regulations, in particular Regulation (EU) 2016/1052, SPIE discloses the following transactions completed from 27 January 2025 to 31 January 2025 under the share buyback programme authorised by the 10th resolution of the SPIE general shareholders’ meeting held on 3 May 2024 and announced on 9 January 2025: Aggregate disclosure per day and per marketName of the issuer Identity code of the Issuer (LEI) Day of transaction ISIN Code Total daily volume (in number of shares) Daily weighted average price of the purchased shares (in euros) Market (MIC Code)SPIE 969500TJNS5GSFWJ8X85 27/01/2025 FR0012757854 42 673 31.2095 XPARSPIE 969500TJNS5GSFWJ8X85 27/01/2025 FR0012757854 32 846 31.2692 CEUXSPIE 969500TJNS5GSFWJ8X85 27/01/2025 FR0012757854 9 291 31.2662 TQEXSPIE 969500TJNS5GSFWJ8X85 27/01/2025 FR0012757854 6...

Continue reading

Aramis Group – Declaration of transactions on own shares conducted from Jan 27 to Jan 31, 2025

PRESS RELEASE Arcueil, February 3, 2025 Declaration of transactions on own shares conducted from January 27 to January 31, 2025 Within the framework of the authorizations granted by the General Assembly on February 9, 2024, to operate on its shares and in accordance with the regulations related to share buybacks, Aramis Group hereby declares the following purchases of own shares (FR0014003U94) made from January 27 to January 31, 2025 (excluding the liquidity contract):Name of the issuer Issuer identifier code Transaction date Financial instrument identifier code Total daily volume (in number of shares) Daily weighted average purchase price of shares MarketAramis Group 9695002Q984W0T41WB42 2025-01-27 FR0014003U94 11,101 7.6960 XPARAramis Group 9695002Q984W0T41WB42 2025-01-28 FR0014003U94 4,929...

Continue reading

EVS Full Year 2024 results to be announced on Tuesday 18 February 2025

Publication on February 3, 2025.Not regulated information.EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS FULL YEAR 2024 RESULTS TO BE ANNOUNCEDON TUESDAY 18 FEBRUARY 2025 EVS Broadcast Equipment will announce its full year 2024 results on February 18th, 2025, after market closing. CONFERENCE CALL ! PRE-REGISTRATION IS REQUIRED ! The day after, EVS will hold a conference call in English at 10.00 am CET with financial analysts and institutional investors. Other interested parties may join the call in a listen-only mode. The presentation used during the conference call will be available shortly before the call on the EVS website. Participants must register using the link provided below. 1. Online registration: https://events.teams.microsoft.com/event/0d1b606f-6ecb-4455-a5c5-3a69fe5da5af@e61db0b4-dfbe-49fe-acd3-c1668c3573cb ANNONCE...

Continue reading

Coface : agreement to acquire Cedar Rose Group, strengthening its information services in the Middle East and Africa

Coface: agreement to acquire Cedar Rose Group, strengthening its information services in the Middle East and Africa Paris, 3 February 2025 – 17.35 Coface announces that it has signed an agreement with Mr. Antoun Massaad and Mrs. Christina Massaad, co-founders of the company, to acquire the Cedar Rose Group. With over 25 years’ experience, Cedar Rose is one of the leading providers of business information solutions in the Middle East and Africa region. In a region where information is difficult to access and with positive economic growth outlook, Cedar Rose has built up a vast business network enabling it to produce data whose quality is recognized by its customers, including a number of multinationals. Following the acquisition, Cedar Rose will become Coface’s information provider in the region, for both credit insurance and...

Continue reading

Bio-Convert Develops QR-02, a Potential Breakthrough in the Treatment of Oral Leukoplakia 

BEVERLY HILLS, California, Feb. 03, 2025 (GLOBE NEWSWIRE) — Bio-Convert ApS (“Bio-Convert”), a subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting Nordic and U.S. life sciences companies in establishing themselves in the U.S. market, announces the groundbreaking development of QR-02, a unique and proprietary oral topical treatment designed to address oral leukoplakia with moderate to severe dysplasia, a potentially precancerous condition affecting millions worldwide. Addressing a Critical Unmet Medical Need Oral leukoplakia is characterized by white patches or plaques in the mouth, and when accompanied by dysplasia (abnormal cell growth), it becomes a marker of disease progression. Alarmingly, 10-30% of these patients may develop oral...

Continue reading

McEwen Mining: Grey Fox Gold Resources Hit a Significant Milestone

32% Increase in the Indicated Resource to 1,538,000 Ounces of Gold 95% Increase in the Inferred Resource to 458,000 Ounces of Gold TORONTO, Feb. 03, 2025 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is pleased to report a significant increase in the estimated gold (Au) resources at the Fox Complex’s Grey Fox deposit to December 31st, 2024, compared to the last estimate in the 2021 Fox Complex PEA (refer to Table 1). The discovery cost of this increase was US $14.46 per ounce (oz). The deposit itself is subdivided into six different zones: Contact, 147, 147 NE, Grey Fox South (GFS), Gibson & Whiskey-Jack (WJ), shown as yellow stars in Figure 1. An intriguing historic public government record reports that a bulk sample of 8,000 tonnes taken in 1989 from the Gibson zone ramp yielded an average grade in excess...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.